BOSTON SCIENTIFIC CORP (BSX) › Cash & EquivalentsBOSTON SCIENTIFIC CORP (BSX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2006: $1.67B2007: $1.45B2008: $1.64B2009: $864.00M2010: $213.00M2011: $267.00M2012: $207.00M2013: $217.00M2014: $587.00M2015: $319.00M2016: $196.00M2017: $188.00M2018: $146.00M2019: $217.00M2020: $1.73B2021: $1.93B2022: $928.00M2023: $865.00M2024: $414.00M2025: $1.97B$1.97B2006Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.97B+374.6%2024$414.00M-52.1%2023$865.00M-6.8%2022$928.00M-51.8%2021$1.93B+11.0%2020$1.73B+699.1%2019$217.00M+48.6%2018$146.00M-22.3%2017$188.00M-4.1%2016$196.00M-38.6%2015$319.00M-45.7%2014$587.00M+170.5%2013$217.00M+4.8%2012$207.00M-22.5%2011$267.00M+25.4%2010$213.00M-75.3%2009$864.00M-47.3%2008$1.64B+13.0%2007$1.45B-12.9%2006$1.67B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share